FDA Panel Backs Tougher Warning for Tamiflu
TUESDAY, Nov. 27 A U.S. Food and Drug Administration advisory panel strongly recommended Tuesday that the Tamiflu well known as prescription flu drug (oseltamivir) must have a stronger warning on the label to reflect reports of bizarre behaviors and deaths among children who use the medication.
Related posts:
- Under The FDA safety review will be The Pfizer anti-smoking drug
- Nexium was Approved by FDA for Use in Children Ages 1-11 Years
- New Drug Relieving the Symptoms of Rheumatoid Arthritis in Children as Well as in Adults.
- FDA Makes Public Announcements About Adverse Reactions Linked to Botox Use
- FDA Has Warned About The Fake Internet Drugs.
